| NP0331624 | 3,5-dibromo-2-(3′,5′-dibromo-2′-hydroxyphenoxy)phenol | |  | C12H6Br4O3
517.7930 Da 513.70505 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
| NP0331625 | 3,5-dibromo-2-(3′,5′-dibromo-2′-hydroxyphenoxy)anisole | |  | C13H8Br4O3
531.8200 Da 527.72070 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0331626 | 3,4,5-tribromo-2-(3′,5′-dibromo-2′-hydroxyphenoxy)anisole | |  | C13H7Br5O3
610.7160 Da 605.63121 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0331627 | 3,4,5-tribromo-2-(3′,5′-dibromo-2′-hydroxyphenoxy)phenol | |  | C12H5Br5O3
596.6890 Da 591.61556 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
| NP0331628 | 3,4,5,6-tetrabromo-2-(3′,5′-dibromo-2′-hydroxyphenoxy)phenol | |  | C12H4Br6O3
675.5850 Da 669.52607 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
| NP0331629 | panepocyclinol A | |  | C22H25ClO6
420.8900 Da 420.13397 Da | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0331630 | (−)-Pleionol | |  | C23H22O5
378.4240 Da 378.14672 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0331631 | (±)-Blestanol K | |  | C29H26O5
454.5220 Da 454.17802 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0331632 | Isoarundinin I | |  | C22H22O4
350.4140 Da 350.15181 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0331633 | (−)-Bleochrin F | |  | C22H20O4
348.3980 Da 348.13616 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3CN, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) |
|
| NP0331634 | Metaplexigenin 3-O-α-L-cymaropyranosyl-β-D-cymaropyranosyl-(1→4)-α-L-diginopyranosyl-β-D-cymaropyranoside | |  | C51H82O19
999.1980 Da 998.54503 Da | |
| NP0331635 | Kidjoranin 3-O-β-D-cymaropyranosyl-(1 →4)-α-L-diginopyranosyl-(1→4)-β-D-cymaropyranoside | |  | C51H74O16
943.1370 Da 942.49769 Da | |
| NP0331636 | Kidjoranin 3-O-α-L-diginopyranosyl-(1→4)-β-D-cymaropyranoside | |  | C44H62O13
798.9670 Da 798.41904 Da | |
| NP0331637 | Metaplexigenin 3-O-β-D-cymaropyranosyl-(1→4)-α-L-diginopyranosyl-(1→4)-β-D-cymaropyranoside | |  | C44H70O16
855.0280 Da 854.46639 Da | | 1H NMR Spectrum (1D, 400.132470802, C5D5deposition_typeN, simulated) | | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) |
|
| NP0331638 | Metaplexigenin 3-O-α-L-diginopyranosyl-(1→4)-β-D-cymaropyranoside | |  | C37H58O13
710.8580 Da 710.38774 Da | | 1H NMR Spectrum (1D, 400.132470802, C5D5deposition_typeN, simulated) | | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) |
|
| NP0331639 | Punctaporonin T | |  | C19H26O6
350.4110 Da 350.17294 Da | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
| NP0331640 | Punctaporonin U | |  | C15H19O3
247.3140 Da 247.13342 Da | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) |
|
| NP0331641 | Tolypocaibol B | |  | C67H112N14O15
1353.7160 Da 1352.84316 Da | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) |
|
| NP0331642 | Tolypocaibol A | |  | C66H110N14O15
1339.6890 Da 1338.82751 Da | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
| NP0331643 | (−)-Cryptanoside A | |  | C30H42O10
562.6560 Da 562.27780 Da | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) |
|
| NP0331644 | (1 R,4R,5R,7R,9S)-4,5-epoxy-8(14)-caryophyllen-7-ol | |  | C15H24O2
236.3550 Da 236.17763 Da | |
| NP0331645 | Dstramonin B | |  | C21H32O7
396.4800 Da 396.21480 Da | |
| NP0331646 | 14-hydroxycaryophyllene 4,5-oxide | |  | C15H24O2
236.3550 Da 236.17763 Da | |
| NP0331647 | (4 R,5R,7R,10R)-4-hydroxy-eudesma-2,11-dien-1-one | |  | C16H24O
232.3670 Da 232.18272 Da | |
| NP0331648 | Dstramonin C | |  | C19H32O8
388.4570 Da 388.20972 Da | |